Showing results (251-260 of 439) with videos related to

Sort By:
Pageof 44
Annals of Hematology|March 7, 2021
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patientsEmilia Scalzulli, Giovanni Caocci, Fabio Efficace, et al.
Frontiers in Oncology|February 24, 2025
Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasmsEsther Natalie Oliva, Shien Guo, Jennifer Lord-Bessen, et al.
Cell Communication and Signaling : CCS|April 11, 2025
A network-based approach to overcome BCR::ABL1-independent resistance in chronic myeloid leukemiaValeria Bica, Veronica Venafra, Giorgia Massacci, et al.
British Journal of Haematology|August 19, 2020
Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parametersCarmelo Gurnari, Massimo Breccia, Francesca Di Giuliano, et al.
Haematologica|September 14, 2019
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolismLuca Mazzarella, Edoardo Botteri, Anthony Matthews, et al.
Annals of Hematology|June 28, 2018
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemiaLuca Maurillo, Francesco Buccisano, Alessandra Spagnoli, et al.
Annals of Hematology|March 23, 2022
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial groupSara Pepe, Elena Rossi, Malgorzata Trawinska, et al.
The Oncologist|May 25, 2026
Add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: a randomized phase 3 studyJean-Jacques Kiladjian, Uma Borate, Elisabetta Abruzzese, et al.
Haematologica|March 28, 2008
Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcomeFrancesca Palandri, Ilaria Iacobucci, Fausto Castagnetti, et al.
Acta Haematologica|March 18, 2011
Management of the 2009 A/H1N1 influenza pandemic in patients with hematologic diseases: a prospective experience at an Italian centerCorrado Girmenia, Caterina Mercanti, Vincenzo Federico, et al.
Pageof 44